China’s Push for Cheap Covid Drugs Is Hitting Major Roadblocks

Boxes of Pfizer Inc.’s Paxlovid antiviral medication in a warehouse in Shoham, Israel, on Jan. 18, 2022. — Boxes of Pfizer Inc.’s Paxlovid antiviral medication in a warehouse in Shoham, Israel, on Jan. 18, 2022.
Photographer: Kobi Wolf/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Take our Survey

By Bruce Einhorn

January 16, 2023 at 11:00 AM UTC

Hi, it’s Bruce in Hong Kong. China’s push for cheaper Covid antivirals is facing resistance from top US drugmakers just as the country struggles with a record wave of infections. But before we get into that...

The middle of a gigantic virus wave is not the best time to be haggling with Big Pharma over the price of Covid drugs.